Status:
COMPLETED
Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
UFR de Pharmacie (Clermont-Ferrand)
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
Chemotherapy induced peripheral neuropathy (CIPN) is one of the most deleterious adverse effect of neurotoxic anticancer drugs affecting up to 40% of patients. These neurotoxic anticancer agents inclu...
Detailed Description
This observational and cross-sectional study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and ce...
Eligibility Criteria
Inclusion
- Oncologist
Exclusion
- pain physician
Key Trial Info
Start Date :
January 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 23 2019
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT03854864
Start Date
January 14 2019
End Date
March 23 2019
Last Update
May 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont-Ferrand
Clermont-Ferrand, France, 63003